- US11965024utility2024Methods and Compositions for Modulating Beta Chain Mediated Immunity0 cites
- US11952411utility2024Materials and Methods of Using Engineered Ligands0 cites
- US11952426utility2024Methods for Treating Multiple Myeloma0 cites
- US11954627utility2024Smart Label Devices, Systems, and Methods0 cites
- US11956362utility2024Centralized and Decentralized Individualized Medicine Platform0 cites
- US11945798utility2024Substituted Aminopyridine Compounds as EGFR Inhibitors0 cites
- US11945881utility2024Neoantigens Expressed in Ovarian Cancer and Their Uses0 cites
- US11939375utility2024Medical Device for Administering Anti-il-23 Antibodies0 cites
- US11932680utility2024Cd8a-binding Fibronectin Type III Domains0 cites
- US11915428utility2024Method for Determining Severity of Skin Disease Based on Percentage of Body Surface Area Covered by Lesions0 cites
- USD1015529design2024Drug Delivery System0 cites
- USD1015530design2024Drug Delivery System0 cites
- US11890304utility2024Pancreatic Endocrine Cells and Methods Thereof0 cites
- US11884722utility2024Anti-gprc5d Antibodies, Bispecific Antigen Binding Molecules That Bind GPRC5D and CD3, and Uses Thereof0 cites
- US11866499utility2024Monospecific and Multispecific Anti-tmeff2 Antibodies and Their Uses0 cites
- US11833190utility2023Serum Albumin-binding Fibronectin Type III Domains0 cites
- US11827708utility2023Proteins Comprising HLA-G Antigen Binding Domains and Their Uses0 cites